UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                 --------------


                                    FORM 8-K

                                 CURRENT REPORT

                         Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                                 --------------



        Date of Report (Date of earliest event reported): August 8, 2003
                                                          --------------



                                  OXiGENE, INC.
             (Exact name of registrant as specified in its charter)


       Delaware                     0-21990                 13-3679168
   -------------------          ----------------          ---------------
    (State or other               (Commission              (IRS Employer
    jurisdiction of               File Number)            Identification No.)
    incorporation)



                     321 Arsenal Street, Watertown, MA    02472
--------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (617) 673-7800
                                                            -------------







Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

(a) Financial statements of businesses acquired. Not applicable.

(b) Pro forma financial information. Not applicable.

(c) The following exhibits are furnished with this report:

          Exhibit
          Number     Description
          -------    -----------
           99.1      Press Release dated August 8, 2003.

Item 9. Regulation Fair Disclosure.

The following information is furnished pursuant to Item 12, "Disclosure of
Results of Operations and Financial Condition."

OXiGENE issued a news release on August 8, 2003, a copy of which is attached as
Exhibit 99.1 to this report and incorporated herein by this reference, in which
it announced financial results for the second quarter ended June 30, 2003. This
information shall not be deemed to be "filed" for the purposes of Section 18 of
the Securities and Exchange Act of 1934 and shall not be deemed to be
incorporated by reference in any filing under the Securities Act of 1933.







                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                                           OXiGENE, INC.
                                                          (Registrant)



Date: August 8, 2003                                  /s/ Frederick W. Driscoll
                                                          Frederick W. Driscoll